Sai Parenteral's IPO 2026: Date, Price Band, GMP, Lot Size, Review & Should You Apply?
The Sai Parenteral's IPO will open for subscription on March 24, 2026, and close on March 27, 2026. The pharmaceutical company plans to raise ₹408.79 crore through this book-built public offering.
Sai Parenteral's Ltd operates in the pharmaceutical formulations industry, focusing on branded generics and CDMO (Contract Development and Manufacturing Organisation) services for domestic and international markets.
Investors are closely tracking this IPO due to the growing demand for generic medicines, exports, and CDMO opportunities in the global pharmaceutical industry.
In this detailed IPO Ji analysis, we cover Sai Parenteral's IPO dates, price band, GMP, lot size, financials, strengths, risks, and investment outlook.
Sai Parenteral's IPO Key Details
| Particular | Details |
|---|---|
| IPO Opening Date | March 24, 2026 |
| IPO Closing Date | March 27, 2026 |
| Listing Date | April 2, 2026 |
| Price Band | ₹372 – ₹392 |
| Face Value | ₹5 per share |
| Lot Size | 38 shares |
| Minimum Investment | ₹14,896 |
| Issue Size | ₹408.79 crore |
| Issue Type | Book Built Issue |
| Listing Exchange | BSE, NSE |
| Registrar | Bigshare Services Pvt Ltd |
| Lead Manager | Arihant Capital Markets Ltd |
Sai Parenteral's IPO Timeline
| Event | Date |
|---|---|
| IPO Opens | March 24, 2026 |
| IPO Closes | March 27, 2026 |
| Allotment Finalization | March 30, 2026 |
| Refund Initiation | April 1, 2026 |
| Shares Credited | April 1, 2026 |
| Listing Date | April 2, 2026 |
Sai Parenteral's IPO Price Band & Lot Size
The price band for Sai Parenteral's IPO is ₹372 to ₹392 per share.
Investors can apply for a minimum of 38 shares and in multiples thereafter.
Retail Investment
| Application | Shares | Amount |
|---|---|---|
| Minimum | 38 | ₹14,896 |
| Maximum | 494 | ₹1,93,648 |
HNI Investment
| Category | Shares | Amount |
|---|---|---|
| sNII | 532 | ₹2,08,544 |
| bNII | 2,584 | ₹10,12,928 |
Retail investors can apply up to ₹2 lakh using the cut-off price option.
Sai Parenteral's IPO GMP (Grey Market Premium)
The Sai Parenteral's IPO GMP will reflect the grey market sentiment before listing.
GMP generally indicates expected listing gains or discount based on investor demand in the unofficial market.
However, investors should note that GMP is not an official indicator and can change frequently.
Track daily GMP updates on the IPO Ji platform.
About Sai Parenteral's Ltd
Founded in 2001, Sai Parenteral's Ltd is a diversified pharmaceutical formulations company specializing in generic medicines and CDMO services.
The company manufactures and distributes pharmaceutical products across multiple therapeutic segments.
Key Therapeutic Areas
- Cardiovascular
- Neuropsychiatry
- Anti-diabetic
- Respiratory health
- Antibiotics
- Gastroenterology
- Vitamins and supplements
- Dermatology
Products are available in various dosage forms including:
- Injectables
- Tablets
- Capsules
- Liquid orals
- Ointments
Manufacturing Facilities
Sai Parenteral's operates five manufacturing facilities in India.
Four facilities are located in Hyderabad, while one is operated by its subsidiary Revat Laboratories in Andhra Pradesh.
These facilities hold global accreditations such as:
- WHO-GMP certification
- TGA Australia approval
- PIC/S compliance
This allows the company to supply medicines to regulated and semi-regulated international markets.
Export Presence
The company began exporting in FY 2023 after acquiring internationally accredited manufacturing units.
Current export markets include:
- Australia
- New Zealand
- Southeast Asia
- Middle East
- Africa
Sai Parenteral's Financial Performance
| Year | Revenue (₹ Cr) | Profit After Tax (₹ Cr) |
|---|---|---|
| FY23 | 97.03 | 4.38 |
| FY24 | 155.18 | 8.42 |
| FY25 | 163.74 | 14.43 |
| Sep 2025 | 89.43 | 7.76 |
97.03 Cr
4.38 Cr
155.18 Cr
8.42 Cr
163.74 Cr
14.43 Cr
89.43 Cr
7.76 Cr
The company has demonstrated steady revenue growth and improving profitability.
Key Financial Ratios
| Metric | Value |
|---|---|
| ROE | 16.82% |
| ROCE | 28.92% |
| PAT Margin | 8.93% |
| EBITDA Margin | 18.68% |
| Price to Book | 10.89 |
Sai Parenteral's IPO Objectives
The company plans to use IPO proceeds for expansion, R&D, and acquisitions.
| Objective | Amount |
|---|---|
| Manufacturing capacity expansion | ₹110.80 Cr |
| New R&D centre | ₹18.02 Cr |
| Debt repayment | ₹14.30 Cr |
| Working capital | ₹33 Cr |
| Overseas acquisition | ₹35.64 Cr |
These investments aim to expand global reach and strengthen research capabilities.
Sai Parenteral's IPO Strengths
Diversified Pharmaceutical Portfolio
The company offers products across multiple therapeutic areas, reducing dependence on a single segment.
Accredited Manufacturing Facilities
Global certifications enable exports to regulated markets.
Growing CDMO Business
CDMO services provide long-term revenue stability and partnerships with pharmaceutical companies.
Strong Distribution Network
The company supplies to government agencies, hospitals, and pharma distributors across India.
Risks to Consider
High Valuation
The IPO is priced at a P/E ratio of around 72, which appears expensive compared with some pharmaceutical peers.
Moderate Profit Margins
Profit margins remain relatively modest compared to established pharma companies.
Competitive Pharmaceutical Industry
The sector has intense competition from large domestic and multinational pharma companies.
Sai Parenteral's IPO Valuation
| Metric | Value |
|---|---|
| EPS | ₹5.43 |
| P/E Ratio | ~72 |
| Market Cap | ₹1,731 crore |
The valuation suggests premium pricing, so listing gains will depend on market sentiment and subscription demand.
How to Apply for Sai Parenteral's IPO
Investors can apply through:
- Net banking ASBA
- UPI via broker apps
- IPO Ji App
You can also track:
- GMP updates
- Subscription status
- Allotment results
directly on the IPO Ji platform.
FAQs on Sai Parenteral's IPO
When will Sai Parenteral's IPO open?
The Sai Parenteral IPO will open on March 24, 2026.
What is the price band of Sai Parenteral's IPO?
The Sai Parenteral IPO price band is ₹372 to ₹392 per share.
What is the lot size of Sai Parenteral's IPO?
The minimum lot size of Sai Parenteral IPO is 38 shares.
What is the minimum investment for Sai Parenteral's IPO?
Retail investors need ₹14,896 to apply for one lot of Sai Parenteral IPO.
When will Sai Parenteral's IPO list?
The Sai Parenteral IPO shares are expected to list on April 2, 2026.
Sai Parenteral's IPO brings a mid-sized pharmaceutical company with strong manufacturing capabilities and export ambitions to the public markets.
While the company operates in a promising sector, investors should carefully evaluate valuation and growth prospects before applying.
For live GMP, subscription status, and allotment updates, track the IPO on IPO Ji.
